Top Markets
Coin of the day
BNB Plus Corp. BNB Plus Corp.

BNB Plus Corp.

BNBX
Clasificación en acciones #38647
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a... BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Precio por acción
$0.09
Última sincronización: 2026-07-28
Capitalización bursátil
$876.21K
Cambio (1 día)
0.00%
Cambio (1 año)
-97.79%
País
US
Comercio BNB Plus Corp. (BNBX)

Categoría

Historial de rendimiento por dividendo de BNB Plus Corp. (BNBX)
Rendimiento por dividendo (TTM) de BNB Plus Corp. (símbolo bursátil: BNBX) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de BNB Plus Corp. (BNBX) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE